Ingalls & Snyder LLC’s Labcorp LH Stock Holding History

Ingalls & Snyder LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$343K	Buy	1,285 +150	+13%	+$40.6K	0.01%	350
2025 Q4	$285K	Hold	1,135	–	–	0.01%	378
2025 Q3	$326K	Hold	1,135	–	–	0.01%	365
2025 Q2	$298K	Hold	1,135	–	–	0.01%	371
2025 Q1	$264K	Sell	1,135 -54	-5%	-$13.1K	0.01%	385
2024 Q4	$273K	Sell	1,189 -34	-3%	-$7.8K	0.01%	376
2024 Q3	$273K	Buy	1,223 +40	+3%	+$8.79K	0.01%	379
2024 Q2	$241K	Hold	1,183	–	–	0.01%	373
2024 Q1	$258K	Hold	1,183	–	–	0.01%	372
2023 Q4	$269K	Hold	1,183	–	–	0.01%	361
2023 Q3	$238K	Sell	1,183 -194	-14%	-$40.9K	0.01%	376
2023 Q2	$285K	Hold	1,377	–	–	0.01%	362
2023 Q1	$271K	Hold	1,377	–	–	0.01%	358
2022 Q4	$279K	Hold	1,377	–	–	0.02%	358
2022 Q3	$242K	Sell	1,377 -12	-0.9%	-$2.46K	0.01%	364
2022 Q2	$280K	Hold	1,389	–	–	0.01%	358
2022 Q1	$315K	Sell	1,389 -11	-0.8%	-$2.59K	0.01%	366
2021 Q4	$378K	Hold	1,400	–	–	0.02%	348
2021 Q3	$339K	Sell	1,400 -18	-1%	-$4.54K	0.02%	364
2021 Q2	$336K	Sell	1,418 -64	-4%	-$14.6K	0.01%	368
2021 Q1	$325K	Sell	1,482 -17	-1%	-$3.41K	0.02%	352
2020 Q4	$262K	Hold	1,499	–	–	0.01%	364
2020 Q3	$242K	Sell	1,499 -29	-2%	-$4.6K	0.02%	325
2020 Q2	$218K	Buy	+1,528	New	+$211K	0.01%	358
2020 Q1	–	Sell	-1,552	Closed	-$226K	–	426
2019 Q4	$226K	Sell	1,552 -281	-15%	-$40.6K	0.01%	360
2019 Q3	$265K	Hold	1,833	–	–	0.01%	360
2019 Q2	$272K	Hold	1,833	–	–	0.01%	366
2019 Q1	$241K	Buy	+1,833	New	+$226K	0.01%	372
2018 Q4	–	Sell	-1,857	Closed	-$277K	–	430
2018 Q3	$277K	Sell	1,857 -40	-2%	-$6.08K	0.01%	367
2018 Q2	$293K	Buy	1,897 +46	+2%	+$6.94K	0.01%	332
2018 Q1	$257K	Hold	1,851	–	–	0.01%	346
2017 Q4	$254K	Buy	1,851 +140	+8%	+$18.5K	0.01%	349
2017 Q3	$222K	Buy	1,711 +46	+3%	+$6.14K	0.01%	326
2017 Q2	$220K	Sell	1,665 -5	-0.3%	-$612	0.01%	326
2017 Q1	$206K	Buy	+1,670	New	+$198K	0.01%	371
2016 Q4	–	Sell	-1,905	Closed	-$225K	–	422
2016 Q3	$225K	Sell	1,905 -582	-23%	-$68.6K	0.01%	357
2016 Q2	$278K	Hold	2,487	–	–	0.02%	331
2016 Q1	$250K	Hold	2,487	–	–	0.02%	301
2015 Q4	$264K	Hold	2,487	–	–	0.02%	308
2015 Q3	$231K	Hold	2,487	–	–	0.02%	311
2015 Q2	$259K	Buy	2,487 +174	+8%	+$18.1K	0.01%	310
2015 Q1	$250K	Buy	+2,313	New	+$238K	0.01%	317
2013 Q4	–	Sell	-2,863	Closed	-$243K	–	355
2013 Q3	$243K	Sell	2,863 -23,602	-89%	-$1.99M	0.01%	300
2013 Q2	$2.27M	Buy	+26,465	New	+$2.2M	0.14%	109

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ingalls & Snyder LLC's LH Position: Q1 2026 in Review

Ingalls & Snyder LLC increased its Labcorp (LH) stake by 13% in Q1 2026, buying an estimated $40.6K and bringing the position to 1,285 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #350.

Ingalls & Snyder LLC first reported a position in LH in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.27M in Q2 2013. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Ingalls & Snyder LLC held 1,285 shares of Labcorp worth $343K as of Q1 2026.
Ingalls & Snyder LLC bought 150 Labcorp shares in Q1 2026, an estimated $40.6K.
Labcorp made up 0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #350 holding.
Ingalls & Snyder LLC first reported a position in Labcorp in Q2 2013 and has held it in 44 quarters since.
Ingalls & Snyder LLC's Labcorp position peaked at $2.27M in Q2 2013.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.